
- GCV Symposium keynote interview: “As investors, we need… •
- GCV Symposium panel: Energy and Mobility •
- GCV Symposium fireside chat: Looking beyond the short… •
- GCV Symposium keynote: CVCs as change agents •
- Daily Deal Round Up: May 18, 2022 •
- Corporate venturing grows tepidly in April •
- Britain’s innovation space is stronger than ever despite… •
- Covid-19 drove more corporations to explore venture capital •
- Why do many Venture Capital Funded Start-ups shut… •
- Media sector still in the game after the… •
- Security provides the platform •
- Booming CVC is about to get a reality… •
Exit
Daily Deal Round Up: May 17, 2022
The Global Corporate Venturing deal net rounds up investments from across the corporate innovation ecosystem.
Daily Deal Round Up: May 16, 2022
The Global Corporate Venturing deal net rounds up the smaller investments from across the corporate innovation ecosystem.
Daily Deal Round Up: May 12, 2022
The Global Corporate Venturing deal net rounds up the smaller investments from across the corporate innovation ecosystem.
Daily Deal Round Up: May 11, 2022
The Global Corporate Venturing deal net rounds up the smaller investments from across the corporate innovation ecosystem.
Daily Deal Round Up: May 3, 2022
Web3 services provider Venly and genomic analysis technology provider Genome Insight each raised $23m while Rui Ye Lian helped Cedarlake Capital close a $189m fund.
HilleVax racks up $200m in its IPO
The Takeda Vaccines spinoff floated in an upsized offering that granted its former parent $100m in shares.
Daily Deal Round Up: April 29, 2022
Content personalisation technology provider Movable Ink and carbon-negative concrete developer Brimstone each raised $55m, with Intel and Amazon respectively among the investors.
Daily Deal Round Up: April 28, 2022
Call centre software producer Replicant closed a $78m series B round backed by Salesforce Ventures while Ashvattha Therapeutics raised $69m from investors including strategic partner Huadong Medicine.
Other News
Daily Deal Round Up: April 27, 2022
Corporate-backed medical imaging technology producer Lunit is preparing to float in South Korea while cancer drug developer Pheast secured $76m from investors including Alexandria Venture Investments.
Daily Deal Round Up: April 26, 2022
Yangtze River Pharmaceutical Group led Binhui Biopharm's $47m series B-plus round while Sigfox has been snapped up by UnaBiz for under $30m after raising over $300m.
GemPharmatech gets $175m in initial public offering
The Sinopharm-backed laboratory animal model developer floated on Shanghai Stock Exchange’s Star Market two years after its last equity funding.
Daily Deal Round Up: April 20, 2022
Accenture, Workday and Bank of America helped VR training technology developer Strivr expand its latest round to $65m while Consensys backed a $50m round for blockchain analytics provider Flipside Crypto.
Deezer agrees $1.1bn reverse merger
The audio streaming service is set to list with help from a PIPE deal featuring Orange, Access Industries, Warner Music, UMG and Media Participations.
Daily Deal Round Up: April 19, 2022
Citi Ventures, Salesforce Ventures and Telstra Ventures all invested in blockchain infrastructure provider Blockdaemon's series D round while GV backed cybersecurity software provider Obsidian's $90m series C.
Editor's Picks
Deezer agrees $1.1bn reverse merger
The audio streaming service is set to list with help from a PIPE deal featuring Orange, Access Industries, Warner Music, UMG and Media Participations.
Bolt ties on $1.5bn Wyre purchase
Kraken, OK Group, 9fBank and Baofoo are in line to exit Wyre, with its cryptocurrency infrastructure technology to strengthen Bolt's one-click checkout offering.
Fast hits the wall
The Stripe-backed rapid checkout tool developer was valued at $1bn early last year but is closing its doors after failing to raise more cash.
GoTo gets $1.1bn in initial public offering
The multicorporate-backed diversified mobile app operator has listed on IDX having priced its shares at near the top of their range.